Abbott plots new paths to clinical trial diversity, joining biopharma push for broader inclusion
Clinical trials have a diversity problem. That’s the opening statement on Abbott’s new website to promote its latest diversity efforts …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
